Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.
Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 3
Abstract
Microglia play a crucial role in the maintenance of neuronal homeostasis in the central nervous system, and microglia production of immune factors is believed to play an important role in nociceptive transmission. There is increasing evidence that uncontrolled activation of microglial cells under neuropathic pain conditions induces the release of proinflammatory cytokines (interleukin - IL-1beta, IL-6, tumor necrosis factor - TNF-alpha), complement components (C1q, C3, C4, C5, C5a) and other substances that facilitate pain transmission. Additionally, microglia activation can lead to altered activity of opioid systems and neuropathic pain is characterized by resistance to morphine. Pharmacological attenuation of glial activation represents a novel approach for controlling neuropathic pain. It has been found that propentofylline, pentoxifylline, fluorocitrate and minocycline decrease microglial activation and inhibit proinflammatory cytokines, thereby suppressing the development of neuropathic pain. The results of many studies support the idea that modulation of glial and neuroimmune activation may be a potential therapeutic mechanism for enhancement of morphine analgesia. Researchers and pharmacological companies have embarked on a new approach to the control of microglial activity, which is to search for substances that activate anti-inflammatory cytokines like IL-10. IL-10 is very interesting since it reduces allodynia and hyperalgesia by suppressing the production and activity of TNF-alpha, IL-1beta and IL-6. Some glial inhibitors, which are safe and clinically well tolerated, are potential useful agents for treatment of neuropathic pain and for the prevention of tolerance to morphine analgesia. Targeting glial activation is a clinically promising method for treatment of neuropathic pain.
Authors and Affiliations
Joanna Mika
Keywords
Related Articles
- EP ID EP128980
- DOI -
- Views 121
- Downloads 0
Potential hepato-protective effect of α-tocopherol or simvastatin in aged rats.
Background: The effect of α-tocopherol or simvastatin treatment on antioxidant defense in liver of old rats was investigated. Methods: Endogenous thiobarbituric acid reactive substances (TBARS) and total nitrite/nitrate...
Novel mechanistic and clinical implications concerning the safety of statin discontinuation.
The beneficial effects of statins have been discussed widely, and their preventative role has been confirmed in cardiovascular disorders, primary and secondary prevention settings, and in asymptomatic subjects with a hig...
Lipid peroxidation, isoprostanes and vascular damage.
Increased lipid peroxidation has been identified as a key mechanism for the development of atherosclerosis and inflammatory vascular damage. Determination of plasma concentration and urinary excretion of some F(2)-isopro...
Effect of exposure to fluoride and acetaminophen on oxidative/nitrosative status of liver and kidney in male and female rats.
Background: This study was undertaken to investigate, the effect of 6 weeks treatment with acetaminophen (AAP) and fluoride (F), administered either separately or together, on nitric oxide generation, lipid and protein p...
Impact of postnatal dexamethasone on psychotomimetic effects of MK-801 measured on adult rats.
The present study investigates the impact of dexamethasone (DEX) given in tapering doses in the postnatal period on MK-801-induced locomotor activity and MK-801-evoked deficits of sensorimotor gating of adult rats (60 da...